These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 5140007

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Irreversible enzyme inhibitors. CXLIV. Proteolytic enzymes. VII. Additonal active-site-directed irreversible inhibitors of trypsin derived from m- and p-(phenoxyalkoxy)benzamidines with a terminal sulfonyl fluoride.
    Baker BR, Erickson EH.
    J Med Chem; 1969 Jan; 12(1):112-7. PubMed ID: 5763005
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Irreversible enzyme inhibitors. CXV. Proteolytic enzymes. V. Active-site-directed irreversible inhibitors of trypsin derived from p-(phenoxyalkoxy) benzamidines with a terminal sulfonyl fluoride.
    Baker BR, Erickson EH.
    J Med Chem; 1968 Mar; 11(2):245-9. PubMed ID: 5654210
    [No Abstract] [Full Text] [Related]

  • 10. Irreversible enzyme inhibitors. CLXV. Proteolytic enzymes. XV. Inhibition of guinea pig complement by derivatives of m-phenoxypropoxybenzamidine.
    Baker BR, Cory M.
    J Med Chem; 1969 Nov; 12(6):1053-6. PubMed ID: 5389147
    [No Abstract] [Full Text] [Related]

  • 11. Comparative inhibition of thrombin, plasmin, trypsin, and complement by benzamidines using substituent constants and regression analysis.
    Coats EA.
    J Med Chem; 1973 Oct; 16(10):1102-6. PubMed ID: 4270699
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Structure-activity relationships in immunochemistry. 2. Inhibition of complement by benzamidines.
    Hansch C, Yoshimoto M.
    J Med Chem; 1974 Nov; 17(11):1160-7. PubMed ID: 4415920
    [No Abstract] [Full Text] [Related]

  • 16. Irreversible enzyme inhibitors. 138. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 6-(p-aminomethylphenethyl)-- 2,4-diamino-5-(3,4-dichlorophenyl)pyrimidine with a terminal sulfonyl fluoride.
    Baker BR, Vermeulen NM.
    J Med Chem; 1969 Jan; 12(1):89-91. PubMed ID: 5763048
    [No Abstract] [Full Text] [Related]

  • 17. Synthesis and structure-activity study of protease inhibitors. III. Amidinophenols and their benzoyl esters.
    Yaegashi T, Nunomura S, Okutome T, Nakayama T, Kurumi M, Sakurai Y, Aoyama T, Fujii S.
    Chem Pharm Bull (Tokyo); 1984 Nov; 32(11):4466-77. PubMed ID: 6532549
    [No Abstract] [Full Text] [Related]

  • 18. Irreversible enzyme inhibitors. CXXXVII. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 6-(p-aminomethylphenoxymethyl)-2,4-diamino-5-(3,4-dichlorophenyl)pyrimidine bearing a terminal sulfonyl fluoride.
    Baker BR, Vermeulen NM.
    J Med Chem; 1969 Jan; 12(1):86-8. PubMed ID: 5763047
    [No Abstract] [Full Text] [Related]

  • 19. [Synthetic inhibitors of serine proteinases. 4.: Inhibitory effect of substituted anilides of 3- and 4- amidino benzoic acid and amidino-anilides of different benzoic- and benzene sulfonic acids].
    Walsmann P, Landmann H, Markwardt F, Stürzebecher J, Vieweg H, Wagner G.
    Pharmazie; 1974 Jun; 29(6):413-5. PubMed ID: 4277284
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.